Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001470831-26-000174
Filing Date
2026-02-18
Accepted
2026-02-18 17:04:38
Documents
1
Period of Report
2026-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1771452272.html 4  
1 FORM 4 wk-form4_1771452272.xml 4 7055
  Complete submission text file 0001470831-26-000174.txt   8533
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472
Business Address
Mossler Mark (Reporting) CIK: 0001992219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 26649867